Home
ALUR
ALUR News

Latest Allurion Technologies Inc. (ALUR) News on June 7, 2025

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

GOBankingRates

7 days ago

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

3 International Vacations That Are Cheaper Than an iPhone

GOBankingRates

7 days ago

3 International Vacations That Are Cheaper Than an iPhone

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

GOBankingRates

7 days ago

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

This week in Trumponomics: Too bad TACO isn’t true

Yahoo Finance

7 days ago

This week in Trumponomics: Too bad TACO isn’t true

Starmer says Farage would spook the City and give us Truss 2 – he could be right

The Guardian

7 days ago

Starmer says Farage would spook the City and give us Truss 2 – he could be right

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Yahoo Finance Video

7 days ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Benzinga

7 days ago

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Reuters

7 days ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Allurion to Present at Jefferies Global Healthcare Conference

Business Wire

8 days ago

Allurion to Present at Jefferies Global Healthcare Conference

Allurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain Results

Insider Monkey

10 days ago

Allurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain Results

Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program

Business Wire

10 days ago

Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program

GuruFocus.com

23 days ago

Allurion Technologies Inc (ALUR) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...

Allurion Reports First Quarter 2025 Financial Results and Provides Business Update

Business Wire

24 days ago

Allurion Reports First Quarter 2025 Financial Results and Provides Business Update

Allurion Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss

Business Wire

24 days ago

Allurion Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss

What To Expect From Allurion Technologies Inc (ALUR) Q1 2025 Earnings

GuruFocus.com

25 days ago

What To Expect From Allurion Technologies Inc (ALUR) Q1 2025 Earnings

Allurion to Report First Quarter 2025 Financial Results on May 14, 2025

Business Wire

a month ago

Allurion to Report First Quarter 2025 Financial Results on May 14, 2025

Allurion Announces Postponement of Special Meeting of Stockholders

Business Wire

2 months ago

Allurion Announces Postponement of Special Meeting of Stockholders

Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Business Wire

2 months ago

Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Business Wire

3 months ago

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025

Business Wire

3 months ago

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

Business Wire

3 months ago

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion to Participate in Upcoming Investor Conferences

Business Wire

3 months ago

Allurion to Participate in Upcoming Investor Conferences

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Business Wire

4 months ago

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Business Wire

4 months ago

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Business Wire

4 months ago

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Allurion Relaunches in France

Business Wire

4 months ago

Allurion Relaunches in France

How Much Upside is Left in Allurion Technologies, Inc. (ALUR)? Wall Street Analysts Think 374.67%

Zacks

4 months ago

How Much Upside is Left in Allurion Technologies, Inc. (ALUR)? Wall Street Analysts Think 374.67%

Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk

Investor's Business Daily

4 months ago

Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk

Allurion Stock Skyrockets 80% After Hours Following Clinical Study Announcement

GuruFocus.com

4 months ago

Allurion Stock Skyrockets 80% After Hours Following Clinical Study Announcement

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market

Business Wire

4 months ago

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market

Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program

Business Wire

4 months ago

Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program

Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity

Business Wire

5 months ago

Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

Business Wire

5 months ago

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

Allurion Announces Positive Topline Results From AUDACITY Trial

Business Wire

5 months ago

Allurion Announces Positive Topline Results From AUDACITY Trial

Allurion Technologies, Inc. Announces Reverse Stock Split

Business Wire

5 months ago

Allurion Technologies, Inc. Announces Reverse Stock Split

FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next

Yahoo Finance

6 months ago

FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

Business Wire

6 months ago

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

Allurion launches compounded GLP-1 program as FDA aims to end access

Yahoo Finance

6 months ago

Allurion launches compounded GLP-1 program as FDA aims to end access

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

Business Wire

6 months ago

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

Earnings Release: Here's Why Analysts Cut Their Allurion Technologies Inc. (NYSE:ALUR) Price Target To US$1.83

Simply Wall St.

7 months ago

Earnings Release: Here's Why Analysts Cut Their Allurion Technologies Inc. (NYSE:ALUR) Price Target To US$1.83

Allurion Technologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

7 months ago

Allurion Technologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

Business Wire

7 months ago

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference

Business Wire

7 months ago

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024

Business Wire

7 months ago

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon

Business Wire

7 months ago

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon

Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss

Business Wire

8 months ago

Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss

Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss

Business Wire

8 months ago

Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss

Allurion Receives Continued Listing Standards Notice from NYSE

Business Wire

9 months ago

Allurion Receives Continued Listing Standards Notice from NYSE

Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity

Business Wire

9 months ago

Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity

Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors

Business Wire

9 months ago

Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors

Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program

Business Wire

9 months ago

Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program

Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial

Business Wire

10 months ago

Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial

Allurion Receives Continued Listing Standards Notice from NYSE

Business Wire

10 months ago

Allurion Receives Continued Listing Standards Notice from NYSE

Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update

Business Wire

10 months ago

Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update

Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024

Business Wire

a year ago

Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024

Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement

Business Wire

a year ago

Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement

Allurion Announces Launch of Offering of Common Stock and Warrants

Business Wire

a year ago

Allurion Announces Launch of Offering of Common Stock and Warrants

Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss

Business Wire

a year ago

Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss

Sidoti Events, LLC's Virtual June Small-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual June Small-Cap Conference

Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

a year ago

Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery

Business Wire

a year ago

Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

a year ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

a year ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

a year ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer

Business Wire

a year ago

Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer

Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s

Business Wire

a year ago

Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s

Allurion to Participate in Two Upcoming Investor Conferences in June 2024

Business Wire

a year ago

Allurion to Participate in Two Upcoming Investor Conferences in June 2024

Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss

Business Wire

a year ago

Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss

Allurion Reports First Quarter 2024 Financial Results and Provides Business Update

Business Wire

a year ago

Allurion Reports First Quarter 2024 Financial Results and Provides Business Update

Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey

Business Wire

a year ago

Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey

Allurion Announces Preliminary First Quarter 2024 Results

Business Wire

a year ago

Allurion Announces Preliminary First Quarter 2024 Results

Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments

Business Wire

a year ago

Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments

Allurion Expands Virtual Care Suite to the United States

Business Wire

a year ago

Allurion Expands Virtual Care Suite to the United States

Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance

Business Wire

a year ago

Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance

Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Business Wire

a year ago

Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair

Business Wire

a year ago

Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair

Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024

Business Wire

a year ago

Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024

Allurion to Participate in Cowen’s 44th Annual Health Care Conference

Business Wire

a year ago

Allurion to Participate in Cowen’s 44th Annual Health Care Conference

Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Business Wire

a year ago

Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Should You Buy OP Bancorp (NASDAQ:OPBK) For Its Upcoming Dividend?

Simply Wall St.

a year ago

Should You Buy OP Bancorp (NASDAQ:OPBK) For Its Upcoming Dividend?

Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies

Business Wire

a year ago

Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies

European Parliament’s Environment Committee Votes to Support New Proposal for the Regulation of New Genomic Techniques

GlobeNewswire

a year ago

European Parliament’s Environment Committee Votes to Support New Proposal for the Regulation of New Genomic Techniques

Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss

Business Wire

a year ago

Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss

Business Wire

a year ago

Evans Bancorp Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast

Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships

Business Wire

a year ago

Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships

This Forum Energy Technologies Insider Increased Their Holding By 22% Last Year

Simply Wall St.

a year ago

This Forum Energy Technologies Insider Increased Their Holding By 22% Last Year

Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities

Business Wire

a year ago

Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities

Share on Social Networks: